Ascend Wellness Holdings, Inc.
Ascend Wellness Holdings, Inc. is a vertically integrated cannabis operator focused on adult-use and near-term adult-use markets in the United States. The company cultivates, processes, manufactures, and distributes cannabis consumer packaged goods, then sells them through its own dispensaries, retail partner locations, and third-party licensed retailers. Its portfolio spans flower, pre-rolls, infused pre-rolls, concentrates, vapes, edibles, and tablets, with brands such as Ozone, Simply Herb, High Wired, Honor Roll, Royale, and Effin'. Ascend’s operating model is built around state-by-state licensing, owned cultivation and manufacturing assets, and an expanding retail footprint in limited-license markets.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueIndoor and greenhouse cultivation, harvesting, and processing of cannabis plant material into saleable product.
Sale of branded and unbranded cannabis products to retail partners and licensed third-party retailers.
Direct-to-consumer sales through company-owned dispensaries and delivery channels.
Development and commercialization of multi-form-factor brands such as Ozone and Simply Herb.
Products
Reported · share of revenue- Retail67.8 %
- Third Party Wholesale32.2 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Ascend sells to three main customer groups: adult-use consumers shopping in its dispensaries, wholesale buyers at licensed retail locations, and retail partner locations that carry its products. The company’s retail customers are served through an omni-channel model that includes eCommerce, reserve-online-pickup-in-store, delivery where permitted, curbside pickup, and digital consultations. Wholesale customers buy Ascend products because the company offers a broad assortment of form factors and branded products that can be supplied consistently across limited-license state markets. The company also uses retail partner relationships and social equity license partnerships to broaden market access without relying only on fully owned stores.
Buy cannabis products in Ascend-owned dispensaries for convenience, product variety, and brand familiarity.
Licensed dispensaries and retail partners purchase Ascend-branded products to fill shelves with consistent supply and recognized brands.
Customers who order online, use the app, or choose delivery/pickup for convenience and faster fulfillment.
Partner license holders and joint operating structures that expand market access in regulated states.
Strategy
Ascend’s strategy is to expand within limited-license adult-use and near-term adult-use states by opening additional dispensaries under existing licenses and through partnership structures. The company is also focused on increasing cultivation and processing capacity, improving product assortment, and strengthening its branded portfolio across multiple price points. Omni-channel retail capabilities, including a revamped eCommerce platform, loyalty program, app, and delivery, are intended to improve customer retention and basket size. Management also expects acquisitions and selective partnerships to remain part of the growth plan, while capital allocation is constrained by regulation, financing availability, and state-specific licensing rules.
More owned stores increase direct-to-consumer reach and improve control over margins and customer experience.
Vertical integration supports supply reliability, product consistency, and wholesale availability.
Digital tools and loyalty programs help retain customers and increase repeat purchases in a competitive retail market.
Partnerships can expand market access in a regulated industry where licenses are scarce and state rules differ.
Geography
Ascend’s business is concentrated in the United States, with substantially all revenue derived from U.S. cannabis operations. As of year-end 2025, the company had direct or indirect operations or financial interests in seven states: Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. It operates cultivation facilities in six states and sells products to its own retail stores in Illinois, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania, as well as to third-party wholesale customers in Illinois, New Jersey, and Massachusetts. Geography matters because cannabis is regulated state by state, so licensing, local competition, and the pace of adult-use adoption directly shape where Ascend can grow. The company also has delivery programs in Massachusetts, Michigan, and New Jersey, which makes local market density and regulatory permissions important to customer access and sales mix.
Risks
Ascend operates in a highly regulated industry where cannabis remains illegal under U.S. federal law, creating legal, banking, tax, and enforcement uncertainty even when state operations are compliant. Its growth depends on opening new dispensaries, integrating acquisitions, and expanding cultivation capacity, so delays in licensing, construction, or regulatory approvals can slow execution. The business is also exposed to agricultural and manufacturing risks such as pests, mold, crop contamination, equipment failures, and utility disruptions, which can reduce yields and raise costs. Competitive pricing pressure and increased market competition have already affected revenue, and the company also faces risks from supplier dependence, cybersecurity, and the conduct of partners and employees.
- Federal illegality of cannabis in the United StatesImpact: HighLikelihood: High
Even compliant state operators face enforcement, banking, tax, and legal uncertainty because federal law conflicts with state legalization.
Exposure: All U.S. operations
- Pricing pressure and increased competitionImpact: HighLikelihood: High
Management disclosed revenue declines driven by competition and pricing pressure in most markets.
Exposure: Legacy markets
- State licensing and regulatory approval delaysImpact: HighLikelihood: Medium
Dispensary openings, acquisitions, and asset exchanges depend on approvals that can be slow or uncertain.
Exposure: Expansion pipeline and M&A
- Agricultural and cultivation disruptionsImpact: HighLikelihood: Low
Indoor cultivation still depends on stable equipment, utilities, and crop health, and failures can reduce output or require write-downs.
Exposure: Cultivation and processing facilities
- Capital structure and financing dependenceImpact: MediumLikelihood: Medium
Expansion and acquisitions require ongoing access to debt or equity capital, and unfavorable terms could slow growth.
Exposure: Growth initiatives and liquidity
Accounting
Judgemental itemsThe company has acquired and structured transactions through partnership entities, requiring judgment on consolidation and purchase accounting.
Impact: Can change reported revenue base, goodwill, and intangible assets
Cannabis inventory depends on biological growth, processing yields, and market pricing, which can create write-downs if demand weakens.
Impact: Affects gross margin and operating profit
State licenses, dispensary assets, and acquired brands may lose value if market conditions or regulation deteriorate.
Impact: Can create non-cash charges and reduce equity
Dispensaries, cultivation sites, and processing facilities create significant lease-related obligations and depreciation/amortization.
Impact: Affects EBITDA comparability and leverage analysis
Similar listed companies
Publicly listed companies with a comparable business focus.
TerrAscend Corp.
TSNDF · Agricultural Production-Crops
Ayr Wellness Inc.
AYRWF · Medicinal Chemicals & Botanical Products
Trulieve Cannabis Corp.
TRLV · Medicinal Chemicals & Botanical Products
Ascent Industries Co
ACNT · Chemicals & Allied Products
Verano Holdings Corp.
VRNO · Agricultural Production-Crops
Marimed Inc.
MRMD · Medicinal Chemicals & Botanical Products
Last updated: 24/09/2026